Mark Griffiths
Directeur Général chez Dishman Group
Profil
Mark Christopher Griffiths is the founder of COSAM Developments Ltd.
founded in 2008.
He is currently the Chief Executive Officer at Dishman Group and a Director at Dishman Europe Ltd., Dishman Netherlands BV, Dishman Pharma Solutions AG, and Covam Ltd.
He previously held the position of Chief Executive Officer at CARBOGEN AMCIS AG and Global CEO & Non-Independent Director at Carbogen Amcis (India) Ltd.
He was also a Non-Independent Non-Executive Director at Dishman Pharmaceuticals & Chemicals Ltd.
and Dishman Carbogen Amcis Ltd.
He was a Director at Carbogen Amcis Ltd.
Mr. Griffiths graduated from the University of Bristol in 2000.
Postes actifs de Mark Griffiths
| Sociétés | Poste | Début |
|---|---|---|
| Dishman Group | Directeur Général | - |
| Covam Ltd. | Directeur/Membre du Conseil | - |
Dishman Netherlands BV
 Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients. | Directeur/Membre du Conseil | - |
Dishman Pharma Solutions AG
 Dishman Pharma Solutions AG Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Pharma Solutions AG is a Swiss company that manufactures and processes drugs. The company is based in Bubendorf, Switzerland. | Directeur/Membre du Conseil | - |
Dishman Europe Ltd.
 Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Europe Ltd. is a British company that imports and markets a wide range of chemical products and pharmaceutical ingredients. The company is based in London, UK. Dishman Europe was founded in 1997. | Directeur/Membre du Conseil | 10/10/2014 |
Anciens postes connus de Mark Griffiths
| Sociétés | Poste | Fin |
|---|---|---|
CARBOGEN AMCIS AG
 CARBOGEN AMCIS AG Pharmaceuticals: MajorHealth Technology CARBOGEN AMCIS AG provides solutions for the development and supply of drug substances as well as drug products to the pharmaceutical and biopharmaceutical industries. It offers services such as process research, process optimization, formulation, supply of pharmaceutical intermediates, active pharmaceutical ingredients manufacturing, project management, and safety. The company was founded in 2006 and is headquartered in Bubendorf, Switzerland. | Directeur Général | 01/04/2022 |
| DISHMAN CARBOGEN AMCIS LIMITED | Directeur Général | 07/02/2019 |
| COSAM Developments Ltd. | Fondateur | 01/08/2011 |
Carbogen Amcis Ltd.
 Carbogen Amcis Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Carbogen Amcis Ltd. develops and commercializes pharmaceutical products. The company is based in Manchester, UK. Carbogen Amcis was founded in 2005. | Directeur/Membre du Conseil | - |
| ░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | - |
Formation de Mark Griffiths
| University of Bristol | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DISHMAN CARBOGEN AMCIS LIMITED | Health Technology |
| Entreprise privées | 10 |
|---|---|
CARBOGEN AMCIS AG
CARBOGEN AMCIS AG Pharmaceuticals: MajorHealth Technology CARBOGEN AMCIS AG provides solutions for the development and supply of drug substances as well as drug products to the pharmaceutical and biopharmaceutical industries. It offers services such as process research, process optimization, formulation, supply of pharmaceutical intermediates, active pharmaceutical ingredients manufacturing, project management, and safety. The company was founded in 2006 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Dishman Pharmaceuticals & Chemicals Ltd.
 Dishman Pharmaceuticals & Chemicals Ltd. Pharmaceuticals: MajorHealth Technology Dishman Pharmaceuticals & Chemicals Ltd. manufactures and markets drugs, intermediates, fine chemicals and quats. It operates through the following business segments: Contract Research & Manufacturing and Others. The Contract Research & Manufacturing segment develops intermediates and active pharmaceutical ingredients. The others segment trades in bulk drugs, intermediates, quats, specialty chemicals and outsourced goods. The company was founded on June 29, 1983 and is headquartered in Ahmedabad, India. | Health Technology |
Dishman Europe Ltd.
Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Europe Ltd. is a British company that imports and markets a wide range of chemical products and pharmaceutical ingredients. The company is based in London, UK. Dishman Europe was founded in 1997. | Health Technology |
Dishman Netherlands BV
Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients. | Health Technology |
| Dishman Group | |
Carbogen Amcis (India) Ltd.
 Carbogen Amcis (India) Ltd. Pharmaceuticals: MajorHealth Technology Carbogen Amcis (India) Ltd. engages in the manufacture of bulk drugs. It operates through Contract Research and Contract Manufacturing, and Bulk Drugs, Intermediates, Quats, Specialty Chemicals and Traded Goods segments. It offers a portfolio of drug development, and commercialization services to pharmaceutical industry at all stages of new drug development. The company was founded on July 17, 2007 and is headquartered in | Health Technology |
Dishman Pharma Solutions AG
Dishman Pharma Solutions AG Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Pharma Solutions AG is a Swiss company that manufactures and processes drugs. The company is based in Bubendorf, Switzerland. | Health Technology |
| COSAM Developments Ltd. | |
| Covam Ltd. | |
Carbogen Amcis Ltd.
Carbogen Amcis Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Carbogen Amcis Ltd. develops and commercializes pharmaceutical products. The company is based in Manchester, UK. Carbogen Amcis was founded in 2005. | Health Technology |
